With guidance and assistance from your physician, the prescription and treatment process can be initiated. Work with your physician to sign and submit a Start Form, available for download.
If you have questions about the Start Form, please contact us
VPRIV is an enzyme replacement therapy made by Shire. VPRIV is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease1
* These images are representative illustrations only
See below for Important Safety Information
VPRIV® (velaglucerase alfa for injection) is a prescription medication indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.